Experiencing kindness from health staff, having someone to attend clinics with, and not being rushed in appointments are among a handful of factors strongly associated with adolescents in SA staying on HIV treatment.

The use of PrEP remains low in primary care settings, with only 14% of residents polled at East Carolina University not even having heard of the HIV-preventive treatment.

An ultra-long-acting, injectable, and removable formulation of dolutegravir has proved effective in animal models.

Initiating antiretroviral therapy (ART) may reduce the risk for neurocognitive impairment in patients living with HIV, according to study results.

The male partners of adolescent girls and young women in Swaziland and South Africa report substantial HIV risk behaviours, but the data also challenge the stereotypical image of a 'sugar daddy', say researchers at the University of North Carolina at Chapel Hill in the US.